Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DANAHER CORP /DE/ Director's Dealing 2021

Jun 24, 2021

29832_dirs_2021-06-24_edb693ac-7b79-4eda-a29c-217ec6d66e38.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Codex DNA, Inc. (DNAY)
CIK: 0001850079
Period of Report: 2021-06-22

Reporting Person: DANAHER CORP /DE/ (10% Owner)
Reporting Person: Danaher Innovation Center LLC (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-06-22 Common Stock C 2294157 $0.00 Acquired 2294157 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-06-22 Series A Preferred Stock $ C 1751999 Disposed Common Stock (1751999) Indirect
2021-06-22 Series A-1 Preferred Stock $ C 542158 Disposed Common Stock (542158) Indirect

Footnotes

F1: Each share of Series A Preferred Stock and Series A-1 Preferred Stock (collectively, the "Preferred Stock"), par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The right to convert the Preferred Stock into Common Stock had no expiration date.

F2: Held by Danaher Innovation Center LLC. Danaher Innovation Center LLC is an indirect, wholly owned subsidiary of Danaher Corporation. The address of Danaher Innovation Center LLC is 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC 20037.